The aim of the present study was to investigate the association between FGF21 protein levels with metabolic abnormalities and insulin resistance in Mexican Mestizo subjects living with HIV which were under cART treatment, placing special attention to the alterations in relation to the concurrence of overweight/obesity in people living with HIV. The gene discussed is FGF21; the disease is obesity due to melanocortin 4 receptor deficiency.